[The accuracy of CT and tumor markers in the detection of a recurrent ovarian carcinoma].
Twenty-three patients previously diagnosed as having ovarian cancer were examined with both serum tumor markers (CA 125, CA 19-9, TPA, IAP, AFP) and a pelvic CT scan. The tumor markers predict the clinical outcome more accurately than the CT scan. Further, the tumor markers showed a clear correlation with the clinical course. But in one case, however, the tumor markers were seen to reduce below the normal level from chemotherapy, while the CT scan showed a tumor mass. Thus, both, a CT scan and tumor marker assays are felt to be indispensable for detecting the recurrence of an ovarian cancer.
Wakabayashi
Y
Y
Dept. of Radiology, Tokyo Medical College Hospital.
Ishida
J
J
Kotake
F
F
Hirose
M
M
Kawana
K
K
Abe
K
K
Amino
S
S
Negishi
Y
Y
Akiya
K
K
D002288:Adenocarcinoma, Mucinous / Q000175:diagnosis / Q000000981:diagnostic imaging; D002293:Adenocarcinoma, Scirrhous / Q000175:diagnosis / Q000000981:diagnostic imaging; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000000981:diagnostic imaging; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D011237:Predictive Value of Tests; D011379:Prognosis; D014057:Tomography, X-Ray Computed
D014408:Biomarkers, Tumor